Literature DB >> 19221422

Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.

Marcos A Marques1, J Jacob Kulstad, Christopher E Savard, Pattie S Green, Sum P Lee, Suzanne Craft, G Stennis Watson, David G Cook.   

Abstract

Amyloid-beta (Abeta) is cleared from the brain by both proteolytic digestion and transport across the blood-brain-barrier into the peripheral circulatory system. To investigate the role peripheral Abeta levels play in regulating Abeta brain clearance, we measured the clearance of [125I]-Abeta(1-40) injected into the brains of liver-ligated rats that allowed peripheral Abeta levels to be maintained at elevated levels for approximately one hour with/without a single peripheral bolus of unlabeled Abeta(1-40). We found that elevating peripheral Abetalevels significantly decreased [125I]-Abeta(1-40) brain clearance, thus supporting the hypothesis that peripheral Abeta levels regulate Abeta clearance from the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221422      PMCID: PMC3066174          DOI: 10.3233/JAD-2009-0964

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

Authors:  Yasuji Matsuoka; Mitsuo Saito; John LaFrancois; Mariko Saito; Kate Gaynor; Vicki Olm; Lili Wang; Evelyn Casey; Yifan Lu; Chiharu Shiratori; Cynthia Lemere; Karen Duff
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

2.  Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

Authors:  Jorge Ghiso; Marcos Shayo; Miguel Calero; Douglas Ng; Yasushi Tomidokoro; Samuel Gandy; Agueda Rostagno; Blas Frangione
Journal:  J Biol Chem       Date:  2004-08-20       Impact factor: 5.157

Review 3.  The amyloid precursor protein of Alzheimer disease in human brain and blood.

Authors:  Q X Li; S J Fuller; K Beyreuther; C L Masters
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

4.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

5.  Apolipoprotein E influences amyloid-beta clearance from the murine periphery.

Authors:  E Hone; I J Martins; J Fonte; R N Martins
Journal:  J Alzheimers Dis       Date:  2003-02       Impact factor: 4.472

Review 6.  Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

Authors:  R E Tanzi; R D Moir; S L Wagner
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

7.  LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

Authors:  Rashid Deane; Zhenhua Wu; Abhay Sagare; Judianne Davis; Shi Du Yan; Katie Hamm; Feng Xu; Margaret Parisi; Barbra LaRue; Hong Wei Hu; Patricia Spijkers; Huang Guo; Xiaomei Song; Peter J Lenting; William E Van Nostrand; Berislav V Zlokovic
Journal:  Neuron       Date:  2004-08-05       Impact factor: 17.173

Review 8.  Active and passive immunotherapy for neurodegenerative disorders.

Authors:  David L Brody; David M Holtzman
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 9.  Clearing amyloid through the blood-brain barrier.

Authors:  Berislav V Zlokovic
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

10.  RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.

Authors:  Rashid Deane; Shi Du Yan; Ram Kumar Submamaryan; Barbara LaRue; Suzana Jovanovic; Elizabeth Hogg; Deborah Welch; Lawrence Manness; Chang Lin; Jin Yu; Hong Zhu; Jorge Ghiso; Blas Frangione; Alan Stern; Ann Marie Schmidt; Don L Armstrong; Bernd Arnold; Birgit Liliensiek; Peter Nawroth; Florence Hofman; Mark Kindy; David Stern; Berislav Zlokovic
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  23 in total

1.  The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat.

Authors:  Leon M Tai; Helmut Jacobsen; Laurence Ozmen; Alexander Flohr; Roland Jakob-Roetne; Antonello Caruso; Hans-Peter Grimm
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-04-06       Impact factor: 2.745

2.  Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.

Authors:  Kole D Meeker; James S Meabon; David G Cook
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Prion and Prion-like Diseases in Humans: Poster Abstracts.

Authors: 
Journal:  Prion       Date:  2013 Apr/May       Impact factor: 3.931

4.  TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor.

Authors:  Thangiah Geetha; Chen Zheng; Wade C McGregor; B Douglas White; Maria T Diaz-Meco; Jorge Moscat; Jeganathan Ramesh Babu
Journal:  Neurochem Int       Date:  2012-09-24       Impact factor: 3.921

Review 5.  Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.

Authors:  Mitchell P McInerney; Jennifer L Short; Joseph A Nicolazzo
Journal:  AAPS J       Date:  2017-05-01       Impact factor: 4.009

Review 6.  Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-04       Impact factor: 4.006

Review 7.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

8.  Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects.

Authors:  Jose L Cantero; Juan E Iglesias; Koen Van Leemput; Mercedes Atienza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-04       Impact factor: 6.053

Review 9.  Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.

Authors:  Michelle A Erickson; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

10.  Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Xian-Le Bu; Guo-Qiang Cao; Lin-Lin Shen; Yang Xiang; Shu-Sheng Jiao; Yu-Hui Liu; Chi Zhu; Fan Zeng; Qing-Hua Wang; Ye-Ran Wang; Yong He; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurotox Res       Date:  2015-08-05       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.